You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Solid Tumors, MEDI9447, oleclumab, MEDI4736, durvalumab, CD73, PD-L1, EGFRm NSCLC, immunotherapy, pancreatic, colorectal

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +5 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Solid Tumors Trial in Australia, Korea, Republic of, United States (MEDI9447, MEDI9447 and MEDI4736)

Active, not recruiting
  • Solid Tumors
  • MEDI9447
  • MEDI9447 and MEDI4736
  • La Jolla, California
  • +17 more
Nov 21, 2022

Breast Cancer, Ovarian Cancer, Colorectal Cancer Trial in United States (Durvalumab, Tremelimumab)

Completed
Has Results
  • Breast Cancer
  • +4 more
  • New Haven, Connecticut
  • +5 more
Jul 13, 2021

Triple Negative Breast Cancer Trial in Belgium, France (Paclitaxel, Carboplatin, MEDI4736)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Brussels, Belgium
  • +17 more
Feb 28, 2022

Advanced Cancer Trial in United States (Mocetinostat - 50 mg, Mocetinostat - 70 mg, Mocetinostat - 90 mg)

Terminated
Has Results
  • Advanced Cancer
  • Mocetinostat - 50 mg
  • +4 more
  • Mobile, Alabama
  • +14 more
Mar 10, 2021

Pancreatic Ductal Adenocarcinoma Trial in Toronto (Durvalumab, Oleclumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 22, 2023

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston

Active, not recruiting
  • Advanced Colorectal Carcinoma
  • +24 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

NSCLC Trial in Marseille (Durvalumab (MEDI4736), Monalizumab (IPH2201), Oleclumab (MEDI9447))

Recruiting
  • Non-small Cell Lung Cancer
  • Durvalumab (MEDI4736)
  • +5 more
  • Marseille, France
    Assistance Publique Hopitaux de Marseille
Sep 21, 2022

Metastatic Colorectal Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Canada,

Active, not recruiting
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Durvalumab
  • +2 more
  • Phoenix, Arizona
  • +41 more
Jul 16, 2022

Muscle Invasive Bladder Cancer Trial in Boston (Durvalumab, Oleclumab)

Completed
  • Muscle Invasive Bladder Cancer
  • Boston, Massachusetts
  • +1 more
Sep 8, 2022

Brain Metastases From NSCLC Trial (Stereotactic Radiation Therapy, Durvalumab)

Not yet recruiting
  • Brain Metastases From Non-small Cell Lung Cancer
  • (no location specified)
May 24, 2022

Metastatic Angiosarcoma, Metastatic Dedifferentiated Liposarcoma, Metastatic Osteosarcoma Trial in Houston (Durvalumab,

Recruiting
  • Metastatic Angiosarcoma
  • +7 more
  • Durvalumab
  • Oleclumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2021

NSCLC Trial in Worldwide (Durvalumab, Oleclumab, Monalizumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • San Diego, California
  • +197 more
Oct 11, 2022

NSCLC, NSCLC Stage IV Trial in Madison (Durvalumab, Tremelimumab, Stereotactic Body Radiotherapy)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Non-small Cell Lung Cancer Stage IV
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 21, 2022

Intermediate Stage of Hepatocellular Carcinoma, Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, Tremelimumab (Cohort A

Recruiting
  • Intermediate Stage of Hepatocellular Carcinoma
  • Hepatocellular Carcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Oct 6, 2022

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Non Small Cell Lung Cancer, NSCLC, Stage III, Nsclc Trial in Stanford (Durvalumab, Carboplatin, Pemetrexed)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Stanford, California
    Stanford University
Oct 27, 2022

Thyroid Cancer Trial in United States (Durvalumab (Medi4736), Radioiodine (RAI))

Active, not recruiting
  • Thyroid Cancer
  • Durvalumab (Medi4736)
  • Radioiodine (RAI)
  • Basking Ridge, New Jersey
  • +6 more
Jan 25, 2022

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston (drug,

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

Recruiting
  • Advanced Bladder Carcinoma
  • +34 more
  • Atezolizumab
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston

Recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

Pancreatic Ductal Adenocarcinoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in Toronto (Durvalumab, Oleclumab)

Withdrawn
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Durvalumab
  • Oleclumab
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 13, 2020

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Atlanta (Durvalumab,

Active, not recruiting
  • Lung Non-Small Cell Carcinoma
  • +9 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 22, 2022

NSCLC Trial in Worldwide (MEDI4736)

Active, not recruiting
Has Results
  • Non-Small Cell Lung Cancer
  • Goodyear, Arizona
  • +137 more
Jan 23, 2023

Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Not yet recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +4 more
  • Angiography
  • +8 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Sep 22, 2023